Clinical Relevance: Accommodation is crucial for clear near vision and is predominantly affected by presbyopia. The ability to modulate accommodative function with eye drops could offer a pharmacological approach to manage presbyopia.
Background: To investigate the effects of different concentrations of pilocarpine eye drops on ocular accommodation in young volunteers.
Methods: In this prospective study, healthy volunteers with mild or moderate myopia with corrected visual acuity of no less than 20/20 were recruited. Participants underwent four visits for baselining and administration of low (0.75%), medium (1.00%), and high (1.25%) concentrations of pilocarpine eye drops respectively. One eye of each participant was chosen and analysed. Ophthalmologic examinations included objective and subjective refraction, corrected distance visual acuity, intraocular pressure, and pupil size. Accommodation was assessed using the WAM-5500 binocular autorefractor. Accommodation facility and the defocus curve were measured.
Results: Volunteers ( = 24, mean age 23.7 ± 1.5 years) with a mean spherical equivalent of -2.91 ± 1.54 dioptres (D) were recruited. No serious adverse events occurred. All pilocarpine concentrations showed similar pupil constriction without significant intraocular pressure changes ( > 0.05). Pilocarpine induced greater objective refraction changes with higher concentrations (-1.12 ± 1.07D, -1.56 ± 1.38D, -1.68 ± 1.60D for low, medium, and high concentrations, respectively; < 0.01). Subjective refraction showed a similar dose-response. Accommodative response decreased significantly at the 20 cm stimulus for medium and high concentrations ( < 0.05). Corrected distance visual acuity improved beyond -1.00D to + 0.50D defocus after all three pilocarpines. Accommodative facility improved more by 1.25% than 0.75% ( = 0.04).
Conclusions: Pilocarpine eye drops are effective in improving ocular accommodation, with higher concentrations leading to greater accommodative changes. Pilocarpine has potential for managing presbyopia.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/08164622.2025.2452266 | DOI Listing |
Clin Exp Optom
January 2025
Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China.
Clinical Relevance: Accommodation is crucial for clear near vision and is predominantly affected by presbyopia. The ability to modulate accommodative function with eye drops could offer a pharmacological approach to manage presbyopia.
Background: To investigate the effects of different concentrations of pilocarpine eye drops on ocular accommodation in young volunteers.
Biomolecules
January 2025
Department of Neurology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
Reactive astrogliosis and acidosis, common features of epileptogenic lesions, express a high level of astrocytic acid-sensing ion channel-1a (ASIC1a), a proton-gated cation channel and key mediator of responses to neuronal injury. This study investigates the role of astrocytic ASIC1a in cognitive impairment following epilepsy. Status epilepticus (SE) in C57/BL6 mice was induced using lithium-pilocarpine; the impact of ASIC1a on astrocytes was assessed using rAAV-ASIC1a-NC and rAAV-ASIC1a-shRNA, injected in the CA3 region of mice.
View Article and Find Full Text PDFCNS Neurosci Ther
December 2024
The Collaborative Innovation Center of Tissue Damage Repair and Regeneration Medicine of Zunyi Medical University, Zunyi, Guizhou, China.
Objective: The study investigates whether the expression and function of ENT1 can be regulated by inhibiting the JNK signaling pathway, thereby altering the levels of extracellular adenosine and glutamate in neurons, and subsequently affecting the progression of epilepsy.
Methods: The adult male SD rats were randomly divided into four groups: EP + SP600125 group, EP + DMSO group, EP group, and normal control group. The expression levels of ENT1, p-JNK, and JNK in the hippocampus of rats from each experimental group were detected using Western blotting technology.
Clin Ophthalmol
November 2024
Triangle Eye Consultants, Raleigh, NC, USA.
Purpose: To evaluate the efficacy of 0.2% and 0.4% pilocarpine HCl (CSF-1) for the treatment of presbyopia and to determine the contributions of pilocarpine HCl and diclofenac sodium on the efficacy of fixed-dose combination (FDC) formulations.
View Article and Find Full Text PDFFront Neurosci
November 2024
Department of Physiology, Shanxi Medical University, Taiyuan, China.
Objective: To investigate the effect of (+)-borneol on neuroinflammation and microglia phenotype polarization in epileptogenesis and its possible mechanism.
Methods: Based on mouse models of status epilepticus (SE) induced by pilocarpine, and treated with 15 mg/kg (+)-borneol, western-blot was used to detect the expressions of NeuN, Iba-1, TLR4, p65 and p-p65 in the hippocampus. Immunofluorescence was used to detect the expression of apoptosis-related proteins Bax and Bcl-2.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!